TSBX
Turnstone Biologics
TSBX
TSBX
Delisted
TSBX was delisted on the 8th of August, 2025.
28 hedge funds and large institutions have $5.51M invested in Turnstone Biologics in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.5% less ownership
Funds ownership: 49.47% → 47.97% (-1.5%)
14% less capital invested
Capital invested by funds: $6.37M → $5.51M (-$864K)
Holders
28
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$33.3K | |
| 2 | +$30.4K | |
| 3 | +$11.9K | |
| 4 |
Goldman Sachs
New York
|
+$10.2K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$7.57K |
Top Sellers
| 1 | -$253K | |
| 2 | -$27.8K | |
| 3 | -$14.5K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$10K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$7.31K |